E
Actavia Life Sciences, Inc. RASP
$0.004 -$0.0285-87.69%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Net Income 91.84% -690.51% -547.12% -372.13% -1,091.42%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -95.59% -73.80% -79.19% -85.53% -1.75%
Total Other Non-Cash Items -99.31% 790.87% 765.97% 747.06% 822.84%
Change in Net Operating Assets 43.70% 76.20% 420.48% 387.81% 265.50%
Cash from Operations 65.97% 77.27% 97.28% -26.82% 26.15%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -65.00% -77.46% -73.17% 75.00% 7.69%
Total Debt Repaid 70.85% 39.57% 4.36% -115.45% --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -61.17% -90.18% -87.05% 62.32% -34.92%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 96.91% -207.20% 25.70% 80.20% -516.67%
Weiss Ratings